BIOTEST AG (BIO.DE) Stock Price, Forecast & Analysis
Europe - Frankfurt Stock Exchange - FRA:BIO - DE0005227201 - Common Stock
BIO.DE Key Statistics, Chart & Performance
The current stock price of BIO.DE is 42.2 EUR. In the past month the price decreased by -0.47%. In the past year, price decreased by -0.94%.
BIO.DE Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to BIO.DE. When comparing the yearly performance of all stocks, BIO.DE is a bad performer in the overall market: 64.95% of all stocks are doing better.
BIO.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to BIO.DE. BIO.DE has an average financial health and profitability rating.
BIO.DE Financial Highlights
Over the last trailing twelve months BIO.DE reported a non-GAAP Earnings per Share(EPS) of -0.65. The EPS decreased by -117.24% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1.73% | ||
| ROE | -4.81% | ||
| Debt/Equity | 1.26 |
BIO.DE Forecast & Estimates
For the next year, analysts expect an EPS growth of 1600% and a revenue growth 11.95% for BIO.DE
BIO.DE Ownership
BIO.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1AE.DE | ARGENX SE | 64.78 | 42.56B | ||
| ARGX.BR | ARGENX SE | 65.32 | 42.91B | ||
| 22UA.DE | BIONTECH SE-ADR | N/A | 22.13B | ||
| ABVX.PA | ABIVAX SA | N/A | 8.06B | ||
| 2X1.DE | ABIVAX SA | N/A | 8.41B | ||
| GLPG.AS | GALAPAGOS NV | N/A | 1.93B | ||
| GXE.DE | GALAPAGOS NV | N/A | 1.92B | ||
| IVA.PA | INVENTIVA SA | N/A | 1.01B | ||
| 6IV.DE | INVENTIVA SA | N/A | 962.73M | ||
| NANO.PA | NANOBIOTIX | N/A | 886.20M | ||
| 5CV.DE | CUREVAC NV | 6.71 | 876.36M | ||
| PHIL.MI | PHILOGEN SPA | 18.99 | 633.05M |
Related stock screener links
About BIO.DE
Company Profile
Biotest AG is a DE-based company operating in Biotechnology industry. The company is headquartered in Dreieich, Hessen and currently employs 2,495 full-time employees. Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology, and intensive care medicine. The company develops, manufactures, and markets immunoglobulin, coagulation factors, and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.
Company Info
BIOTEST AG
Landsteinerstr. 5
Dreieich HESSEN DE
Employees: 2495
Phone: 4961038010
BIOTEST AG / BIO.DE FAQ
What does BIO do?
Biotest AG is a DE-based company operating in Biotechnology industry. The company is headquartered in Dreieich, Hessen and currently employs 2,495 full-time employees. Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology, and intensive care medicine. The company develops, manufactures, and markets immunoglobulin, coagulation factors, and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.
Can you provide the latest stock price for BIOTEST AG?
The current stock price of BIO.DE is 42.2 EUR. The price decreased by -0.94% in the last trading session.
Does BIO stock pay dividends?
BIOTEST AG (BIO.DE) has a dividend yield of 0.09%. The yearly dividend amount is currently 0.04.
How is the ChartMill rating for BIOTEST AG?
BIO.DE has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Which stock exchange lists BIO stock?
BIO.DE stock is listed on the Frankfurt Stock Exchange exchange.
Can you provide the PE ratio for BIO stock?
BIOTEST AG (BIO.DE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.65).
Can you provide the upcoming earnings date for BIOTEST AG?
BIOTEST AG (BIO.DE) will report earnings on 2025-08-04.